Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy
Launched by SUN YAT-SEN UNIVERSITY · Nov 25, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different surgical methods for treating congenital cataracts in children. Congenital cataracts are cloudy areas in the eye that can affect vision from a young age. The researchers want to see how well a specific technique called posterior continuous curvilinear capsulorhexis (PCCC) works when combined with a procedure known as anterior vitrectomy (A-Vit) compared to using PCCC alone. This study aims to find out which approach gives better results in terms of vision recovery for children with these cataracts.
To participate in this trial, children must be under 18 years old and have bilateral congenital cataracts without any other eye issues. Additionally, they should have been born after 37 weeks of pregnancy and be able to have their pupils dilated normally before the surgery. Participants will receive the surgical treatment and will be monitored to see how well they recover their vision. It's important for families to know that children with a history of eye trauma or previous eye surgery are not eligible for this study. The trial is currently recruiting participants, and it offers an opportunity to contribute to important research that could improve surgical outcomes for young patients with congenital cataracts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children with bilateral congenital cataracts without other ocular abnormalities
- • Gestational age at birth \>37 weeks
- • No more than 18 years old
- • Pupils could dilate normally pre-operation
- • Have signed a consent form
- • Can be followed
- Exclusion Criteria:
- • Intraocular pressure \>21 mmHg
- • History of ocular trauma and intraocular surgery
About Sun Yat Sen University
Sun Yat-sen University, a prestigious institution located in Guangzhou, China, is dedicated to advancing medical research and healthcare innovations. As a leading clinical trial sponsor, the university leverages its extensive academic resources and collaboration with top-tier medical professionals to conduct rigorous clinical studies. Committed to improving patient outcomes and contributing to global health knowledge, Sun Yat-sen University focuses on a wide range of therapeutic areas, employing cutting-edge methodologies to ensure the integrity and efficacy of its research initiatives. Through its clinical trials, the university aims to foster scientific advancements and enhance the quality of care provided to patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Guangzhou, Guangdong, China
Patients applied
Trial Officials
Weirong Chen, MD
Principal Investigator
Zhongshan Ophthalmic Center, Sun Yat-sen University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials